Hear from Xstrahl's CEO, Adrian Treverton, on the future of skin cancer treatment. https://vimeo.com/718012693
The Future of Skin Cancer Treatment
read more
Resources
A Medical Physicist’s Perspective on Superficial & Orthovoltage Radiotherapy
Kilovoltage X-ray equipment maintains an integral role in the modern radiation therapy department for the treatment of non-melanoma skin cancer as well as other benign conditions and palliative applications. The use of low energy, therapeutic X-rays is often a...
SARRP Research Spotlight: Dr. George Wilson
George Wilson, PhD, Chief, Radiation Biology, William Beaumont Hospital Radiation Biology focuses on translational research in the areas of new treatments, combined modalities, and stem cell biology. The group has a heavy emphasis on incorporating molecular,...
Xstrahl in Action: Xstrahl 300 used in Definitive Radiotherapy
Skin cancer is an increasingly common condition, particularly keratinocytic cancers like basal cell carcinoma and cutaneous squamous cell carcinoma. Surgery has been the standard treatment for these, but affects functional and/or cosmetic outcomes. Definitive...
SmART-XPS Specification Flyer
SmART-XPS is one of the Treatment Planning System options for our Small Animal Radiation Research Platform (SARRP), alongside MuriPlan. Both systems have a wide range of features and capabilities. Learn more about SmART-XPS below.
Superficial & Orthovoltage Radiotherapy for the Treatment of Non-Melanoma Skin Cancer and Other Benign Conditions
Non-melanoma skin cancer is the most common cancer in the world today, with approximately 1.5 million cases in 2016—and that number is growing rapidly. While this type of cancer has a low morbidity rate, surgical treatment often leaves patients with dysfunctions,...
SARRP Research Spotlight: Dr. Chandan Guha
Chandan Guha, PhD, Vice Chairman and Professor of Radiation Oncology, Albert Einstein College of Medicine The Albert Einstein College of Medicine and Montefiore founded the Institute for Onco-Physics, allowing the group to do physical sciences in cancer and stem cell...
The S10 Instrumentation Programs: 2021 Updates
Originally posted on the NIH website ORIP's S10 Instrumentation Grant Programs support purchases of state-of-the-art commercially available instruments to enhance research of NIH–funded investigators. Instruments that are awarded are typically too expensive to be...
SARRP Research Spotlight: University of Pennsylvania
Dr. Costas Koumenis, PhD, Professor and Vice-Chair for Research, at the University of Pennsylvania The University of Pennsylvania (UPenn) was an early adopter of SARRP, acquiring a system in 2011 when it was awarded an NIH S-10 grant. UPenn reports total funding in...
Contact Us